Future Technology Forum

13–14 February 2024

Programme

Download programme

13.02.2024

World Trade Center Moscow, entrance No. 4, 1st floor, conference hall 1. ROSATOM

10:00–11:30

What Do the Technologies of the Future Need to Become the Technologies of the Present?

High-tech scientific development is essential to any country that hopes to remain competitive and safeguard its independence, and development in a social service as important as medicine is no exception. Funding flows into science and technology from a wide range of sources that include state corporations and organizations engaged in the real economy. Priority research areas are formed by the need to approach the evaluation of projects for funding in fundamentally new ways and the need for new standards for the content and quality of policies governing science and technology.
State responsibility for the selection of scientific and technological development priorities likewise demands circumspection when taking decisions to support and finance those projects of a scientific nature that can promise the economy and society tangible achievements in the foreseeable future.
To what extent do the goals and priorities of those engaged in science and technology coincide? What important factors influence development? What factors inhibit development? What areas of research are most important to medicine today?

Session topics :
An Ecosystem for Future Technologies

Moderator:

Andrey Fursenko — Aide to the President of the Russian Federation

Panellists:

Vladislav Baranov — Chairman of the Board of Directors, "My Medical Center" Group of Companies

Oleg Gusev — Leading Researcher, Kazan Volga Region Federal University

Dmitry Zauers — Deputy Chairman of the Management Board, Gazprombank

Dmitry Morozov — Founder, Chairman of the Board of Directors, BIOCAD

Irina Panarina — General Manager, AstraZeneca Russia and Eurasia

Alexander Khlunov — General Director, Russian Science Foundation

Front row participant:

Olga Dontsova — Academician, Head of the Section of Physical and Chemical Biology, Department of Biological Sciences, Russian Academy of Sciences; Head of the Department of Chemistry of Natural Compounds, Lomonosov Moscow State University; Professor, Center for Molecular and Cell Biology, Skolkovo Institute of Science and Technology (Skoltech)

World Trade Center Moscow, entrance No. 4, 1st floor, conference hall No. 2. Gazprombank

10:00–11:30

Technologies Helping in the Fight against Neurodegenerative Diseases

Just as life expectancies continue to grow in developed countries, so does the proliferation of age-specific diseases, including neurodegenerative ones, such as Alzheimer’s, Parkinson’s, and motor neurons, among others. That said, contemporary life in cities can be fast-paced and accompanied with high stress levels, which leads to a phenomenon when neurodegenerative pathologies begin to affect ever younger populations. At present, scientists from around the world are trying to understand how these diseases emerge and progress in order to develop a way to prevent them. However, even now some have been successful at creating therapies that can hinder the progression of such diseases, and can even eliminate certain prominent symptoms. Individual therapies allow patients to choose an optimal algorithm for treatment, including pharmacological methods based on genomic analysis, neuro-surgical, and innovative neuro-rehabilitative technologies. What advanced technologies for the diagnosis and treatment of neurodegenerative diseases exist? What is the quickest and most economical method for determining whether there is a heredity risk for developing Alzheimer’s? What is the current status of and what does the future hold for treating neurodegenerative diseases? What personalized programmes for rehabilitating patients with neurodegenerative diseases have proved to be most effective and successful?

Session topics :
Neurotechnologies in Healthcare

Moderator:

Darya Kryuchko — Head of the Department of Translational Medicine and Innovative Technologies, Federal Medical and Biological Agency (FMBA of Russia)

Panellists:

Anna Bogolepova — Head of the Department of Cognitive Disorders, Federal Centre of Brain Research and Neurotechnologies of the Federal Medical-Biological Agency of the Russian Federation; Professor, Department of Neurology, Neurosurgery and Medical Genetics, Pirogov Russian National Research Medical University of the Russian Ministry of Health

Sergey Illarioshkin — Deputy Director for Research, Director of the Brain Institute, The Research Center of Neurology

Denis Kuleshov — Innovator and Chief Executive Officer, Sensor-Tech

Vladimir Mitkevich — Deputy Director, V.A. Engelhardt Institute of Molecular Biology of the Russian Academy of Sciences

Boris Polyaev — Head of the Department of Medical Rehabilitation of Patients with Disorders of the Central Nervous System No. 2; Federal Center for Brain and Neurotechnology of the Federal Medical-Biological Agency of the Russian Federation

Nikolay Shamalov — Director of the Institute of Cerebrovascular Pathology and Stroke, Federal Center for Brain and Neurotechnology of the Federal Medical-Biological Agency of the Russian Federation; Сhief Supernumerary Specialist Neurologist of the Ministry of Health of the Russian Federation

Front row participant:

Evgeny Nikolaev — Professor, Skoltech Center for Molecular and Cellular Biology

World Trade Center Moscow, entrance No. 4, 2nd floor, conference hall 3

10:00–11:30

Genetic and Genomic Technologies: New Opportunities in Diagnostics and Personalization

The creation of gene-therapeutic drugs, something unheard in the not-so-distant past, capable of effectively treating patients with defective genes is a 21st century breakthrough in biological medicine. However, on the path leading to both the development and complete adaptation of gene therapy a number of fundamental challenges must be overcome. The incredible variety of ailments alone makes applying a standard protocol for developing, registering, and commercializing new gene-therapeutic treatments nearly impossible, and instead dictates that new strategic approaches for solving this problem be developed. What is the current state of medicinal genetic diagnosis? Where exactly is the advantage of creating and using biobanks? What are the end results of the first year of neonatal screening and non-invasive prenatal DNA screening as part of clinical practices?

Session topics :
Genetic Technologies: Part of the Medicine of the Future

Moderator:

Maria Vorontsova — Member of the Presidium, Russian Association for the Promotion of Science

Panellists:

Oksana Drapkina — Director, National Medical Research Center for Therapy and Preventive Medicine of the Ministry of Health of the Russian Federation

Evgeny Imyanitov — Head of the Scientific Department of Biology of Tumor Growth, N.N. Petrov National Medical Research Center of Oncology

Georgy Kostyuk — Chief Physician, N.А. Alekseev Psychiatric Clinical Hospital No. 1 of the Moscow City Health Department; Chief Psychiatrist of the Moscow City Health Department

Dmitry Kudlay — Vice President for the Introduction of New Medical Technologies, Generium

Sergey Kutsev — Director, Academician N.P. Bochkov Medical Genetic Research Center; Chief Freelance Specialist in Medical Genetics of the Ministry of Health of Russia

Maksim Patrushev — Acting Head of the NBICS Nature-like Technologies Complex, National Research Centre ‘Kurchatov Institute’

Olesya Sagaidak — Deputy Medical Director, EVOGEN; Researcher, Federal State Budgetary Institution "National Medical Research Center of Cardiology" of the Ministry of Health of Russia

Konstantin Severinov — General Director, Biotek Campus

Dmitry Trofimov — Director, Institute of Reproductive Genetics, Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology of the Ministry of Health of the Russian Federation

World Trade Center Moscow, entrance No. 4, 2nd floor, conference hall 4

10:00–11:30

Regenerative Medicine and Cell Technologies: Looking into the Future

Regenerative medicine is concerned with the renewal and regeneration of the musculoskeletal system and cartilage and how to reverse the effects of injury and disease. Doctors apply advanced cell technologies and tissue-engineered drugs in therapy. Bioengineers develop materials with new properties to produce implants applied in traumatology and orthopaedics. Regenerative medicine could potentially extend human life, replacing worn-out organs and tissue with biotechnical analogues created through 3D bioprinting. The technology already exists to store human cells in a functional state for many years to reactivate when needed. Doing so would change the face of medicine. In the future, it will be possible to grow tissue to replace worn-out cartilage, teeth, skin, blood, and then organs, and then even fragments of brain tissue without having to worry about the body’s rejecting them. Will we ever learn how to kickstart the process of regeneration in our bodies? What is the immediate outlook for the development of regenerative medicine and cell technologies? What is component is most important to the development of regenerative medicine? How safe are cell technologies? How effective are regenerative medicine and cell technologies and what is keeping us from introducing them into clinical practice today?

Session topics :
Regenerative Medicine: A Way to Restore Health

Moderator:

Anastasia Efimenko — Head of the Laboratory of Tissue Repair and Regeneration, Institute of Regenerative Medicine, Medical Scientific and Educational Center, Lomonosov Moscow State University

Panellists:

Ekaterina Vorotelak — Head of the Laboratory of Cell Biology, N.K. Koltsov Institute of Developmental Biology of the Russian Academy of Sciences

Ilya Eremin — Deputy Director for Research, Academician B.V. Petrovsky Russian Scientific Center for Surgery

Marya Lagarkova — General Director, Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency

Alexey Lundup — Director of the Scientific and Educational Resource Center for Cellular Technologies, Patrice Lumumba Peoples' Friendship University of Russia

Olga Stepanova — Head of the Laboratory of Cell Biology and Regenerative Medicine, V. Serbsky National Medical Research Centre for Psychiatry and Narcology of the Ministry of Health of the Russian Federation

World Trade Center Moscow, entrance No. 4, 2nd floor, conference hall 5

10:00–11:30

Promising Technologies for Use in Traumatology and Orthopaedics

Traumatology and orthopaedics are rapidly advancing areas of clinical medicine. According to data from a recent study by the Global Burden of Disease (GBD), some 1.7 billion people worldwide suffer from musculoskeletal system diseases, which have been the leading cause of disabilities. Over the past 30 years, their prevalence has increased by 62%, and the number of years when people must live with such a disability has increased by 59%. According to this study, Russia is in a group of countries with the highest prevalence of degenerative spinal diseases and osteoarthritis of large joints. Therefore, the introduction of high-tech treatment methods into orthopaedics focusing on sustainable restoration of the functions of the musculoskeletal system is an important social task. For example, surgical treatment of hip fractures in older people (using endo-prosthetics or osteosynthesis) contributes to a significant increase in life expectancy, a return to the patient’s previous level of activity, and results in the reduction of cases of disability. Today, high-tech methods are used in almost all areas of orthopaedics and traumatology, which in turn help in the development of new directions, while reducing both surgery times and the frequency of human error. What advanced reconstructive surgical technologies help increase life expectancies? What advanced technologies for exo-prosthetics of the upper and lower extremities are used most successfully in clinical practice today? What are the latest advances in the surgical treatment of paediatric patients? What will promote the use of additive, navigation, and robotic technologies in traumatology and orthopaedics?

Session topics :
Regenerative Medicine: A Way to Restore Health

Moderator:

Evgeniy Goncharov — Head of the Department of Traumatology and Orthopedics, Academician B.V. Petrovsky Russian Scientific Centre of Surgery

Panellists:

Sergey Vissarionov — Director, G.I. Turner National Medical Research Center for Children's Orthopedics and Trauma of the Ministry of Health of the Russian Federation

Vadim Dubrov — Head of the Department of Traumatology, Orthopedics and Disaster Medicine, Faculty of Fundamental Medicine, Lomonosov Moscow State University

Nikolay Konovalov — Deputy Director for Research, N.N. Burdenko National Medical Research Center of Neurosurgery of the Ministry of Health of the Russian Federation

Anton Nazarenko — Director, N.N. Priorov National Medical Research Center for Traumatology and Orthopedics of the Ministry of Health of Russian Federation; Chief Freelance Specialist Traumatologist-Orthopedist of the Ministry of Health of the Russian Federation

Rashid Tikhilov — Director, R.R. Vreden Russian Scientific Research Institute of Traumatology and Orthopedics of the Ministry of Health of the Russian Federation

Front row participants:

Alexander Burtsev — Director, Academician G.A. Ilizarov National Medical Research Center for Traumatology and Orthopedics of the Ministry of Health of the Russian Federation

Dmitriy Dzukaev — Head, Moscow City Spinal Neurosurgical Center, L.A. Vorokhobov State Budgetary Health Care Institution of Moscow City Clinical Hospital No. 67 of the Moscow Healthcare Department

Sergey Salikhov — First Vice-Rector, MISIS University of Science and Technology

World Trade Center Moscow, entrance No. 4, 2nd floor, conference hall 6

10:00–11:30

Triad of Future Biosecurity: Genomic Surveillance, Big Data and Mobile Technologies

Russia is one of the leaders in ensuring biological safety and, as such, provides assistance to other states in this area. A triad of technologies is successfully used to timely forecast and promptly respond to biological safety threats and provides an analysis of the sanitary and epidemiological situation in the country: genomic surveillance, mobile technologies and big data analytics (including AI analytics), and big data, super-integration technologies. Already today, an entire infrastructure has been created, including mobile laboratory complexes, which allow, in nearly real time, to identify new pathogens and changes in the virulence of known strains of bacteria circulating in Russia and neighbouring countries. Enhancing technologies that make it possible to quickly identify new pathogens is a strategically important mission for Russia and will allow us to analyse the situation so authorities can react quickly and proactively. Which technologies for genomic surveillance and big data analysis for biosafety are available today and are being implemented both in Russia and around the world? What will the mobile laboratories of the future be like and what innovations will influence their development? What developments are most effective for promptly responding to threats and increasing the level of biosafety in Russia?

Session topics :
Technological Sovereignty in Biological Safety

Moderator:

Anna Popova — Head of the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing – Chief State Sanitary Physician of the Russian Federation

Panellists:

Sergey Borisevich — Head, 48 Central Scientific Research Institute of the Ministry of Defense of the Russian Federation

Vadim Govorun — Director, Research Institute of System Biology and Medicine (RISBM)

Elena Ilyina — Chief Researcher, Research Institute for Systems Biology and Medicine (RISBM)

Josefina Campos — Senior Technical Advisor for the International Pathogen Surveillance Network (IPSN), World Health Organisation Hub for Pandemic and Epidemic Intelligence

Vladimir Kutyrev — Director, Russian Anti-Plague Scientific Research Institute "Microbe"

Alexander Lukashev — Director, Martsinovsky Institute of Medical Parasitology, Tropical and Vector-Borne Diseases, I.M. Sechenov First Moscow State Medical University

Areg Totolian — Director, Pasteur Saint-Petersburg Scientific Research Institute of Epidemiology and Microbiology

Jelena Jankovic — Assistant of Minister, Ministry of Health of the Republic of Serbia

World Trade Center Moscow, entrance No. 4, 1st floor, conference hall 1. ROSATOM

12:00–13:30

Meeting of the Working Group on the Legal Regulation of Genetic Technologies, Including Genome Editing, and Bioethics Preventing Hereditary Diseases and Promoting Reproductive and Genetic Well-Being

As medical practice adopts more genetic technologies, it becomes easier and more affordable for expecting parents to prevent hereditary disease in their future child. Preconception screening can identify major recessive genetic disorders in expectant parents, determine the risk of transmitting the mutations to the child, and suggest interventions, technologies, and approaches capable of increasing the child’s chances at good health. The many ethical issues inherent to such tests and the genetic nature of mutations in autosomal recessive diseases continue to pose challenges to specialists attempting to interpret the results of the screening, with similar challenges facing the pharmaceutical industry as it works to develop high-tech drugs for the treatment of rare and orphan diseases. This session seeks to promote dialogue in the expert community on the relationship between expanded preconception and prenatal screening and the potential for reducing the frequency of congenital disorders in the country.

Session topics :
Genetic Technologies: Part of the Medicine of the Future

Moderator:

Maria Vorontsova — Member of the Presidium, Russian Association for the Promotion of Science

Panellists:

Oleg Grin — Director, Scientific and Educational Center for Law and Bioethics in the Field of Genomic Research and Application of Genetic Technologies, Kutafin Moscow State Law University (MSAL)

Igor Kogan — Director, D.O. Otta Scientific Research Institute of Obstetrics, Gynecology and Reproductology

Dmitry Kudlay — Vice President for the Introduction of New Medical Technologies, Generium

Elena Nechaeva — Deputy Chief of the Presidential Directorate for Science and Education Policy

Dmitry Trofimov — Director, Institute of Reproductive Genetics, Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology of the Ministry of Health of the Russian Federation

Alexander Khokhlov — Rector, Yaroslavl State Medical University of the Ministry of Health of the Russian Federation

World Trade Center Moscow, entrance No. 4, 1st floor, conference hall No. 2. Gazprombank

12:00–13:30

Healthy Aging: Active Longevity

An aging population is inevitably accompanied by an increase in the prevalence of chronic non-communicable diseases and geriatric syndromes, as well as a boost in the proportion of elderly people in the population with reduced functionality and dependent on outside help. In this regard, the goal of achieving healthy active longevity is becoming particularly urgent. Slowing down aging may be 10 times more effective at prolonging a healthy life than preventing individual age-associated diseases. The paradigm of modern medicine is how to develop and introduce active longevity technologies using our understanding of the aging process. Thus, future technologies utilized to address active longevity will be a synthesis of modern organizational solutions to prevent and diagnose diseases at an early stage, which include the latest approaches toward treating diseases and technologies that make it possible to manage aging by carrying out truly personalized prevention and treatment. Ultimately, the introduction of these technologies in the near future will result in the delaying of the age at which diseases develop and in the extension of the period of healthy life. What technologies for the prevention and treatment of cognitive impairment are successfully being used now and will appear in the near future? What modern technologies are being used today to reduce mortality from cardiovascular diseases in different age groups? What innovative technologies for preventing premature aging are the most promising? What system of measures is most effective for maintaining one’s health and active longevity?

Session topics :
Biotechnologies in Personalized Healthcare, Including Active Longevity and Preventive Medicine Technologies

Moderator:

Alexey Moskalev — Director of the Research Institute of Aging Biology, N.I. Lobachevsky National Research Nizhny Novgorod State University

Panellists:

David Areshidze — Head of the Laboratory of Cell Pathology, Academician B.V. Petrovsky Russian Scientific Center for Surgery

Oksana Drapkina — Director, National Medical Research Center for Therapy and Preventive Medicine of the Ministry of Health of the Russian Federation

Vladimir Zhuikov — Executive Director, Investment Department, Russian Direct Investment Fund

Kamila Zarubina — Vice President, Executive Director of the Cluster of Biological and Medical Technologies, Skolkovo Foundation

Inna Reshetova — Chief Physician, Clinic of Preventive Medicine, Academician B.V. Petrovsky Russian Scientific Center for Surgery

Gennady Suhih — Director, Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology of the Ministry of Health of the Russian Federation

Olga Tkacheva — Director of the Russian Gerontological Research and Clinical Center, Research Institute of Translational Medicine, N.I. Pirogov Russian National Research Medical University; Chief Freelance Specialist Geriatrician of the Ministry of Health of the Russian Federation

Svetlana Shport — General Director, Serbsky National Medical Research Centre for Psychiatry and Narcology of Ministry of Heath of the Russian Federation; Chief freelance psychiatrist of the Ministry of Health of the Russian Federation

Sergey Yudin — Director, Center for Strategic Planning and Management of Medical and Biological Health Risks of the Federal Medical and Biological Agency of Russia

World Trade Center Moscow, entrance No. 4, 2nd floor, conference hall 3

12:00–13:30

Advanced Technologies in Cardiology and Cardiovascular Surgery

Circulatory system diseases are the leading cause of death worldwide. Healthcare costs for the treatment of acute and chronic diseases of the heart and blood vessels are continually on the rise, while the rate of reduction in mortality has not reached the desired levels, the attainment of which would require innovative approaches toward treatment and prevention. Since 2018, the Russian Federation has been rolling out its Federal Project ‘Combating Cardiovascular Diseases’, which primarily focuses on predicting and assessing genetic risks, personalizing medicine in cardiology, using artificial intelligence, and introducing innovations in treatment and cardiovascular surgery. In this regard, the significance of related sectors and the latest developments, such as training and simulating technologies, is increasing. What are the main challenges and trends in the development of cardiology and cardiovascular surgery today? What best practices is Russia currently rolling out for managing the risks associated with cardiovascular fatalities, including primary and secondary prevention, developing educational initiatives, and organizing rehabilitation? How should the effectiveness of innovations in cardiology and cardiovascular surgery be evaluated in accordance with economic, social, and practical criteria?

Session topics :
Biotechnologies in Personalized Healthcare, Including Active Longevity and Preventive Medicine Technologies

Moderator:

Simon Matskeplishvili — Deputy Scientific Director, Lomonosov Moscow State University Clinic; Member of the Board, Russian Society of Cardiology

Panellists:

Elena Vasilyeva — Chief cardiologist, Moscow Department of Health; Head of the Laboratory of Atherothrombosis, Russian University of Medicine of the Ministry of Health of the Russian Federation, City Clinical Hospital named after. I.V. Davydovsky Department of Health of Moscow

Elena Golukhova — Director, A.N. Bakulev National Medical Research Center for Cardiovascular Surgery of the Ministry of Health of the Russian Federation; Chief Freelance Specialist Arrhythmologist of the Ministry of Health of the Russian Federation

Alexandra Konradi — Deputy General Director for Research, Almazov National Medical Research Centre, Ministry of Health of the Russian Federation

Philip Kopylov — Director of the Institute of Personalized Cardiology, I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation

Sofia Milenkina — Cardiologist, “Cardioatlas” Monograph Author

Natalia Mitkovskaya — Director, State Institution "Republican Scientific and Practical Center "Cardiology" of the Ministry of Health of the Republic of Belarus

Philipp Paleev — Deputy General Director for Scientific and Analytical Work, National Medical Research Center of Cardiology of the Ministry of Health of the Russian Federation

Eduard Charchyan — Head of the Department of Reconstructive Cardiovascular Surgery, Academician B.V. Petrovsky Russian Scientific Center for Surgery

Front row participant:

Sergey Abugov — Head of the Department of X-ray surgical methods of diagnosis and treatment, Russian Scientific Center for Surgery named after Academician B.V. Petrovsky

World Trade Center Moscow, entrance No. 4, 2nd floor, conference hall 4

12:00–13:30

Technologies of the Future for Motherhood and Childhood

The most rapidly-paced progress in clinical medicine can be found in gynaecology, obstetrics, and neonatology. The demographic situation in the Russian Federation predicates that only the most advanced methods for preserving the reproductive function of patients be implemented and that innovative methods to care for premature infants be quickly developed, in addition to utilizing only the latest respiratory and nutritional technologies. Approaches toward diagnosing and treating surgically malformations of the foetus, both scientific and practical, are also constantly being improved. Recent advances in intrauterine diseases and the ability to identify genetic disorders before conception to prevent the passing of diseases to an unborn child have contributed to a dramatic reduction in the incidences of inherited diseases. What advanced technologies and capabilities, including those using artificial intelligence, will be used in the gynaecology, obstetrics, and neonatology of the future? How will the latest techniques for preserving the reproductive function of patients affect motherhood and the demographic situation in Russia? What developments are key to combating intrauterine diseases and critical obstetric conditions, and preserving reproductive potential?

Session topics :
Biotechnologies in Personalized Healthcare, Including Active Longevity and Preventive Medicine Technologies

Moderator:

Dmitry Morozov — Director, Veltischev Research and Clinical Institute for Pediatrics of the N.I. Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation; Chief Freelance Pediatric Surgeon of the Ministry of Health of the Russian Federation

Panellists:

Leila Adamyan — Deputy Director for Research, Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology; Chief Freelance Specialist in Gynecology of the Ministry of Health of the Russian Federation

Dmitry Ivanov — Rector, St. Petersburg State Pediatric Medical University of the Ministry of Health of the Russian Federation; Chief Freelance Specialist Neonatologist of the Ministry of Health of the Russian Federation

Leila Namazova-Baranova — Head, Research Institute of Pediatrics and Child Health Protection, Research and Clinical Center No. 2 of the Academician B.V. Petrovsky Russian Scientific Center for Surgery; Chief Freelance Children's Specialist in Preventive Medicine of the Ministry of Health of the Russian Federation

Elena Petryaykina — Director, Russian Children's Clinical Hospital – Branch of N.I. Pirogov National Medical and Surgical Center of the Ministry of Health of the Russian Federation

World Trade Center Moscow, entrance No. 4, 2nd floor, conference hall 6

12:00–13:30

Digital Technologies as the Basis for Medical Safety in Manufacturing

Digital technologies are widespread in the economy, social spheres, and throughout industry. The transition to digital services in all industries is inevitable, including those with harmful and dangerous factors that can potentially affect a worker’s health adversely. The development of digital technologies makes it possible to digitize data that can assess industrial production, as well as monitor the impact of individual factors on the human body, an activity in which employers are already engaged in today. In line with this, the latest digital devices appearing on the market every year are capable of assessing the slightest changes in workers’ health, as well as understanding the impact certain factors have on employees’ working environment. These devices are mostly used by medical professionals to monitor the health of workers and quickly identify factors that may prevent workers from engaging in certain types of activities. At the same time, more and more people in the world are themselves monitoring their own health by carrying devices and gadgets on their person, which provide personal information about each person to big data databases for instant processing by artificial intelligence, and then receive back recommendations on how to maintain their health. Therefore, the conditions have already been created for the establishment of a unified digital ecosystem with the wilful participation of employees, employers, and medical organizations. What digital technologies are already helping to preserve the health of workers today? In the immediate future, which areas have the most promise, and which ones are moving at the quickest pace developing digital technologies? How soon can we expect the completion of the transition to digital services in all domestic production?

Session topics :
Digitalization and AI Technologies

In partnership with Russian Railways

Moderator:

Elena Zhidkova — Head of the Central Directorate of Healthcare – a branch of Russian Railways

Panellists:

Igor Buhtiyarov — Director, Izmerov Research Institute of Occupational Health; Head of the Department of Occupational Medicine, Aviation, Space and Diving Medicine, I.M. Sechenov First Moscow State Medical University; Chief Supernumerary Specialist in Occupational Pathology, Ministry of Health of the Russian Federation

Pavel Pugachev — Deputy Minister of Health of the Russian Federation

Andrey Pudov — State Secretary – Deputy Minister of Labor and Social Protection of the Russian Federation

Alexey Fetisov — General Director, T1

Evgeny Charkin — Deputy Managing Director, Russian Railways

Front row participants:

Lyubov Zelenkina — Head of the Department for Health Protection of the Department of Industrial and Environmental Safety, Labor Protection and Civil Protection, Gazprom Neft

Irina Larionova — Head of Medical and Sanitary Unit No. 9, Federal Medical-Biological Agency of the Russian Federation

World Trade Center Moscow, entrance No. 4, 1st floor, conference hall 1. ROSATOM

14:00–15:30

Meeting of the BRICS Working Group on Nuclear Medicine

New cancer cases and high mortality and disability rates are being reported among able-bodied people worldwide with increasing frequency even as the demand for modern nuclear medicine in national healthcare systems grows. Nuclear medicine is being applied clinically across fields, with radionuclide diagnostics becoming routine in the detection of malignant neoplasms and in cardiology and neurology among others. Modern therapeutic methods employing radioisotopes in medicine (targeted alpha therapy, theranostics) are increasingly common in the treatment of various types of cancer. There is significant potential in BRICS for the development and application of nuclear medicine for the diagnosis and treatment of oncological and non-oncological diseases alike. In July 2023, more than 200 representatives from BRICS members Brazil, Russia, India, China, and South Africa participated in the International BRICS Expert Forum on Nuclear Medicine in Moscow and Obninsk. The result was a consolidation of recommendations and proposals from the professional expert community for the development of nuclear medicine and radiopharmaceuticals in BRICS. The initiative was endorsed during the BRICS Health Ministers’ Meeting held in August 2023, and it was recommended that a working group be established to explore the initiatives and other possible projects. The establishment of the working group was welcomed during the BRICS Summit, and all nations were encouraged to join in the task. The group’s first meeting is scheduled to take place soon and will look to discuss and confirm the structure of the group and plans for 2024 and review its first initiatives in nuclear medicine. Overviews will also be presented on the outlook for nuclear medicine in new BRICS members showing an interest in consolidating efforts and working together.

Session topics :
Biotechnologies in Personalized Healthcare, Including Active Longevity and Preventive Medicine Technologies

Moderators:

Kirill Komarov — First Deputy General Director, Director of the Development and International Business Unit, State Atomic Energy Corporation ROSATOM

Andrey Stanzhevsky — Deputy Director for Research, Academician A.M. Granova Scientific Center of Radiology and Surgical Technologies of the Ministry of Health of the Russian Federation

Panellists:

Mehshrad Abassi — Professor of Nuclear Medicine, Tehran University of Medical Sciences; Director of the Nuclear Medicine Department, Khomeini Hospital

Tesfaye Henok Abebe — Head of the Clinical Nuclear Medicine Department, St. Paul's Hospital Millennium Medical College

Sergey Glagolev — Deputy Minister of Health of the Russian Federation

Masha Maharaj — Head of Nuclear Medicine Department, Netcare Umhlanga and Hibiscus Hospitals; Secretary, World Association of Radiopharmaceutical and Molecular Therapy (WARMTH)

Anil Kumar Mishra — Professor, Indian Institute of Technology Roorkee

Yehia Omar — Director of PET/CT and Theranostics Unit, Misr Radiology Center

Daria Ryzhkova — Head of Scientific and Clinical Association of Nuclear Medicine, Almazov National Medical Research Centre of the Ministry of Health of the Russian Federation

Front row participants:

Jin Du — Chief Technology Officer, China Isotope and Radiation Corporation (CIRC)

Rafael Lopes — President, Brazilian Society of Nuclear Medicine and Molecular Imaging; Director of the Department of Radionuclide Diagnostics and Therapy, Hospital do Coração

Peter Louw — General Manager, NTP Radioisotopes SOC Ltd.

Prabha Ethiraj — President, Society of Nuclear Medicine India

World Trade Center Moscow, entrance No. 4, 1st floor, conference hall No. 2. Gazprombank

14:00–15:30

Technologies Used at Reference Centres to Monitor National Security

To raise the national biological safety system’s level of sensitivity in Russia, a system of reference centres has been created, whose primary mission is to ensure the country’s biological safety. There are more than 70 such centres, many of which are based on the leading scientific organizations of the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing. Reference centres are the leading scientific and technological link of the national biosafety system, where they analyse epidemiological risks and pathogens of infectious and parasitic diseases, introduce achievements of synthetic biology, the latest technologies for studying pathogens, and the state of natural foci, while also conducting in-depth molecular genetic research. Yet, microorganisms inevitably evolve, which leads to the emergence of new infections and the ensuing race for biotechnology advancement increases the risk that pathogens will be used illegally, including those created artificially. What latest technologies are being used by reference centres to ensure biological safety in Russia? What digital, genetic, and biotechnologies will be used in reference centres in the near future for effective monitoring? How do reference centres respond to biosecurity threats domestically and internationally? How does the system of reference centres influence the development of the entire healthcare system?

Session topics :
Technological Sovereignty in Biological Safety

Moderator:

Vladimir Kutyrev — Director, Russian Anti-Plague Scientific Research Institute "Microbe"

Panellists:

Andrey Biryukov — Head of the Reference Center for Infectious and Viral Oncopathology, Academician B.V. Petrovsky Russian Scientific Center of Surgery

Vadim Govorun — Director, Research Institute of System Biology and Medicine (RISBM)

Roman Kozlov — Chief Freelance Specialist of the Ministry of Health of the Russian Federation for Clinical Microbiology and Antimicrobial Resistance; President, Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy (IACMAC); Rector, Smolensk State Medical University

Dmitry Kutaev — Deputy Head for Research, 48 Central Scientific Research Institute of the Ministry of Defense of the Russian Federation

Lyudmila Mikhaleva — Director, Avtsyn Research Institute of Human Morphology of the Petrovsky National Research Centre of Surgery

Alexey Noskov — Director, Rostov-on-Don Plague Control Researsh Institute

Sergey Tsarev — Head of the Reference Center for Verification of Information about the Biological Threat of the Spread of Immunodeficiency States of the Human Body and Related Infections, National Research Center – Institute of Immunology Federal Medical-Biological Agency of Russia

World Trade Center Moscow, entrance No. 4, 2nd floor, conference hall 3

14:00–15:30

Why Aren’t Science and Business Better Friends and Why Do Scientists Trust only the State?

Government funding of science in Russia has increased significantly over the past 20 years. This is a positive trend that has allowed the country to make significant upgrades to research infrastructure and set the standard in a number of scientific areas. The current situation in the world has Russia following the lead of BRICS members states, which are developing dynamically and possess the resources necessary to lead the way technologically. As countries like China use business to drive scientific achievement, the correlation between investment in science involving the business community and growth in GDP is clear. How can we move past just supporting science to start investing in it? Are state efforts enough to ensure technological sovereignty? How can we engage business in the development of future technologies? What kind of relationship should exist between business and scientific institutions to ensure collaboration is mutually beneficial? What success stories already exist and what can we do to ensure best practices spread?

Session topics :
An Ecosystem for Future Technologies

Moderator:

Valeria Kasamara — Director, Association of Organizers of Student Olympiads "I am a Professional"

Panellists:

Igor Drozdov — Chairman of the Board, Skolkovo Foundation

Dmitry Zauers — Deputy Chairman of the Management Board, Gazprombank

Aydar Ishmukhametov — Director General, Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products of the Russian Academy of Sciences

Maxim Ostras — Director of Strategic Development, LIFT Center; Head, QLU

Ekaterina Solntseva — Chief Digital Officer, State Atomic Energy Corporation ROSATOM

Irina Khvorostyan — Partner, Head of Technology Practice, KEPT

Vyacheslav Shulenin — General Director, Moscow Center for Healthcare Innovations

World Trade Center Moscow, entrance No. 4, 2nd floor, conference hall 4

14:00–15:30

Creation of Artificial Organs and Biological Systems: Technologies of the Future

Transplantology is a special field of medicine that aims to treat patients with the most severe cases. Advancements in recent years in domestic vital organ transplantation have made it possible to transform this field into a truly accessible form of medical care for citizens of the Russian Federation. High levels of scientific research in this area, as well as a focus on achieving practical results, including the creation of artificial, bio-artificial organs, and high-tech equipment, are all very significant for strengthening Russia’s technological and biomedical sovereignty. Prospects for the development of transplantology involve the creation of compact implantable biological systems and technical devices that could become an effective alternative to human organs, as well as the development of ways to achieve active longevity in otherwise doomed patients. What makes modern transplantology the aggregate of high life-saving technologies? What trends in creating an artificial heart are the most relevant today? What modern technologies for clinical lung and heart-lung transplantation have been successfully introduced into clinical practice? What do the results achieved in the use of innovative technologies for donor organ perfusion in clinical practice indicate? What advanced technologies in transplantology will appear in the near future?

Session topics :
Regenerative Medicine: A Way to Restore Health

Moderator:

Yousef Khesuani — Co-founder, Managing Partner, 3D Bioprinting Solutions

Panellists:

Sergey Gotye — Director, Academician V.I. Shumakov National Medical Research Center for Transplantology and Artificial Organs of the Ministry of Health of the Russian Federation; Chief Freelance Specialist Transplantologist of the Ministry of Health of the Russian Federation

Maria Loginova — Head of the Laboratory of Applied Immunogenetics, Kirov Scientific Research Institute of Hematology and Blood Transfusion of the Federal Medical and Biological Agency

Elena Parovichnikova — General Director, National Medical Research Center for Hematology of the Ministry of Health of the Russian Federation; Chief Freelance Specialist Hematologist of the Ministry of Health of the Russian Federation

Oleg Rummo — Director, Minsk Scientific and Practical Center for Surgery and Transplantology and Hematology

Timur Khalilulin — Professor of the Department of Transplantology and Artificial Organs, I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation

Front row participants:

Ilya Bozo — Director General, Gistograft; Head of the Division of Maxillofacial and Reconstructive Plastic Surgery, Petrovsky National Research Centre of Surgery

Marina Minina — Head of the Moscow Coordination Center for Organ Donation, S.P. Botkin City Clinical Hospital of the Moscow City Health Department

Vladislav Parfenov — Head of the Scientific Projects Implementation Group, Science and Innovations

World Trade Center Moscow, entrance No. 4, 2nd floor, conference hall 5

14:00–15:30

Public Meeting of the Council for the Implementation of the Federal Scientific and Technical Program for the Development of Genetic Technologies for 2019–2030

Genetic technologies are a priority for Russia’s Scientific and Technological Development Strategy. Presidential Decree No. 680 dated 28 November 2018 on the Federal Scientific and Technical Programme for the Development of Genetic Technologies for 2019–2030 was introduced to better coordinate among the Russian genetic scientists working on state tasks for the development of genetic technologies in the country. The aim of the programme is to provide an effective approach to the problems of accelerating the development of genome editing and other genetic technologies, laying the necessary scientific and technological groundwork, improving measures in place to prevent biological emergencies, and ensuring national security. The programme has brought together a wide range of participants and support measures and provided for the creation of essential infrastructure while strengthening human resources and developing a network of scientific laboratories, world-class genetic research centres, and core facilities. Genetic technologies have been classified as cross-cutting, and the head of state has resolved to engage qualified customers, industrial partners, and the technological partner Rosneft. Up for consideration during the meeting will be five years of programme work, important achievements already reached, and priorities for what lies ahead.

Session topics :
Genetic Technologies: Part of the Medicine of the Future

Moderator:

Tatyana Golikova — Deputy Prime Minister of the Russian Federation

Panellists:

Mikhail Kovalchuk — President, National Research Centre "Kurchatov Institute"

Dmitry Kuprash — Member of the Scientific Council, V.A. Engelhardt Institute of Molecular Biology of the Russian Academy of Sciences

Dmitry Morozov — Founder, Chairman of the Board of Directors, BIOCAD

Anna Popova — Head of the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing – Chief State Sanitary Physician of the Russian Federation

Dmitriy Pyshnyy — Deputy Minister of Science and Higher Education of the Russian Federation

Denis Sekirinsky — Deputy Minister of Science and Higher Education of the Russian Federation

Andrey Fursenko — Aide to the President of the Russian Federation

Andrey Shishkin — Vice-President for Localization, Innovation and Energy, Rosneft

World Trade Center Moscow, entrance No. 4, 2nd floor, conference hall 6

14:00–15:30

Technologies for the Non-Viral Delivery of Nucleic Acids: Gene Therapy of the Future

The development of genetic technologies has created the possibility to correct gene defects that can lead to hereditary diseases and also made it possible to create a wide array of potential therapies for the standard treatment of cancer. The main tool for the delivery of genetic material to cells is currently viral vectors. However, this technology is fraught with many disadvantages and limitations. The immunogenicity of viral vectors can cause various side effects during their introduction and, furthermore, may never be used again. Capacity restrictions of the viral genome prevent it from delivering many therapeutic genes with long nucleotide sequences. Bearing this in mind, it is extremely relevant to develop zero-risk systems for the delivery of nucleic acids, including genetic editing tools, in order to somehow circumvent these restrictions. Technologies that can ensure the effective delivery of genes with long nucleotide sequences, including genome editing systems, will expand the areas where genetic therapy is used and will significantly reduce the cost of such therapy, making genetic therapy drugs more accessible to patients in Russia. What are the latest achievements in genetic therapy as we look to the future? What influence will new technologies have on the spectrum of application and accessibility of genetic therapy? What possibilities do modern technologies possess for delivering virus-free genes? What new areas of therapeutic application of genome editing tools currently exist?

Session topics :
Genetic Technologies: Part of the Medicine of the Future

Moderator:

Vladimir Gushchin — Head, Laboratory of Mechanisms for the Population Variability of Pathogenic Microorganisms, Honorary Academician N.F. Gamaleya National Research Center for Epidemiology and Microbiology of the Ministry of Health of the Russian Federation

Panellists:

Irina Alekseenko — Head of the Gene Immunoncotherapy Group, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences

Oleg Batishchev — Deputy Director for Scientific Work, A.N. Frumkin Institute of Physical Chemistry and Electrochemistry of the Russian Academy of Sciences

Roman Ivanov — Director of the Scientific Center for Translational Medicine, Vice-Rector for Scientific and Technological Development, Sirius University of Science and Technology

Dmitry Kostyushev — Head of the Laboratory of Genetic Technologies in the Development of Medicines, I.M. Sechenov First Moscow State Medical University of the Ministry of Healthcare of the Russian Federation

Musa Khaitov — Director, National Research Center – Institute of Immunology Federal Medical-Biological Agency of Russia

World Trade Center Moscow, entrance No. 4, 1st floor, conference hall 1. ROSATOM

16:00–17:30

Innovative Oncology

One of the key problems of modern medicine is the prevention and early detection of cancer. Scientists are attaching special importance to the creation of breakthrough technologies and the expansion of interdisciplinary interaction with their scientific colleagues – biologists, chemists, bioinformaticians, physicists, and mathematicians. Specifically, this refers to the introduction of artificial intelligence technologies into screening systems, the design and development of the latest approaches toward molecular genetic diagnostics, as well as the development and production of domestic models of heavy equipment and radiopharmaceuticals. Scientists are especially focused on personalized approaches towards curing cancer. Biotechnological developments are underway in the field of oncology. This includes cell therapy, mRNA vaccine therapy, therapy with oncolytic viral strains, as well as developments in gene editing and gene therapy. What innovative technological solutions and biotechnologies are the most effective for the treatment of malignant neoplasms? What prospects for the use of biotechnological drugs exist today? What are the key challenges facing the scientific and medical community when improving methods for the treatment of oncological diseases?

Session topics :
Biotechnologies in Personalized Healthcare, Including Active Longevity and Preventive Medicine Technologies

Moderator:

Sergey Ivanov — Director, A.F. Tsyb Medical Radiological Research Center – branch of the National Medical Research Center for Radiology of the Ministry of Health of the Russian Federation; Chief Freelance Oncologist of the Central Federal District of the Ministry of Health of the Russian Federation

Panellists:

Irina Baldueva — Head of the Scientific Department of Oncoimmunology, Leading Researcher, N.N. Petrov National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation

Aleksandr Gintsburg — Director, Honorary Academician N.F. Gamaleya National Research Center for Epidemiology and Microbiology of the Ministry of Health of the Russian Federation

Dmitry Gorin — Full Professor, Center for Photonic Science and Engineering, Skolkovo Institute of Science and Technology (Skoltech)

Aydar Ishmukhametov — Director General, Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products of the Russian Academy of Sciences

Andrey Kaprin — General Director, Federal State Budgetary Institution National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation; Сhief Freelance Specialist Oncologist of the Ministry of Health of the Russian Federation

Vasily Lazarev — Deputy General Director for Research, Head of the Genetic Engineering Laboratory, Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency

Alexander Petrovskiy — Deputy Director for Educational Activities, N.N. Blokhin National Medical Research Center of Oncology оf the Ministry of Health of the Russian Federation

Igor Khatkov — Director, GBUZ Moscow Clinical Scientific Center named after Loginov of the Department of Healthcare of Moscow

World Trade Center Moscow, entrance No. 4, 1st floor, conference hall No. 2. Gazprombank

16:00–17:30

Biotechnologies for the Diagnosis and Treatment of Autoimmune Diseases

Autoimmune diseases are a significant challenge for medical science. Due to the fact that these diseases cause premature disability and an unfavourable life prognosis for patients (economic losses are comparable to those incurred when fighting cancer), they carry great social significance. In last decade, there has been a tendency towards an increase in the frequency of autoimmune pathologies, at a time when existing methods for treating such diseases are not able to deal with the root causes of autoimmune destruction, and are instead only focused on eliminating the consequences. Recently, Russian scientists staged a coup in the study and treatment of autoimmune diseases – the development in Russia of a unique, fundamentally new approach in pharmacotherapy of autoimmune pathologies that can become a platform for future treatments of a wide range of diseases from this group, in particular type I diabetes, which mainly manifests in children. How are innovative discoveries in autoimmunology changing the face of today’s medicine and how far has medical science advanced in the study of autoimmune diseases? Are there prerequisites for individualizing the treatment of AIDs as part of the concept of personalized medicine? What are the prospects for the further integration of innovative solutions in treating autoimmune diseases and in hands-on healthcare?

Session topics :
Biotechnologies in Personalized Healthcare, Including Active Longevity and Preventive Medicine Technologies

In partnership with R-pharm

Moderator:

Aleksandr Lila — Director, V.A. Nasonova Research Institute of Rheumatology; Chief Freelance Specialist Rheumatologist of the Ministry of Health of the Russian Federation

Panellists:

Natalia Mokrysheva — Director, Head of the Department of Personalized and Translational Medicine, National Medical Research Center of Endocrinology, Ministry of Health of the Russian Federation; Corresponding Member of the Russian Academy of Sciences

Evgeny Nasonov — Academic Director, V.A. Nasonova Research Institute of Rheumatology

Mikhail Samsonov — Chief Medical Officer, R Pharm

Ekaterina Troshina — Deputy Director – Director of the Institute of Clinical Endocrinology, National Medical Research Center for Endocrinology of the Ministry of Health of the Russian Federation

Dmitry Chudakov — Acting Director, Research Institute of Translational Medicine, N.I. Pirogov Russian National Research Medical University

Pavel Yakovlev — Deputy General Director for Early Development and Research of a Biotechnology Company, BIOCAD

World Trade Center Moscow, entrance No. 4, 2nd floor, conference hall 3

16:00–17:30

The Interdisciplinary Nature of Future Technologies: Synergy

It is becoming clearer that vital technological breakthroughs will occur where different fields of knowledge meet. Biotechnology, artificial intelligence, quantum technologies, and new materials are just some of the many complementary disciplines that exist. Interdisciplinary research leads to emergent properties and transforms the technological landscape. What new areas of research might emerge? How do different technologies uncover solutions in other areas? What can we do to stimulate research where scientific disciplines intersect? What technologies will define future technological progress?

Session topics :
An Ecosystem for Future Technologies

Moderator:

Dmitry Chermoshentsev — Senior Researcher, Russian Quantum Center

Panellists:

Oleg Zhuravlev — General Director, Wormhols Implementation

Leonid Koldunov — Lecturer, Department of General Physics, Moscow Institute of Physics and Technology (National Research University)

Alexander Korsunsky — Professor, Skoltech Center for Systems Engineering

Igor Nabiev — Director of the Nano-photon scientific center, National Research Nuclear University "MEPhI"

Alexey Osadchy — Leading Research Fellow, AIRI Institute of Artificial Intelligence; Director, Centre for Bioelectric Interfaces, Institute for Cognitive Neuroscience, National Research University Higher School of Economics

Ilya Semerikov — Researcher at the Laboratory "Optics of Complex Quantum Systems", Lebedev Physical Institute of the Russian Academy of Sciences

Guzel Ulumbekova — Head, Higher School of Healthcare Organization and Management

Alexander Fertman — Director of Science and Education Department, Skolkovo Foundation

World Trade Center Moscow, entrance No. 4, 2nd floor, conference hall 4

16:00–17:30

Healthcare Management Technologies amidst Digital Transformation

This new technological structure found in healthcare, brought on by modern breakthrough technologies such as blockchain, artificial intelligence, the Internet of things, metaverses, big data, and cloud computing, has forced the industry to undergo a complete digital transformation. Not only is the image of medicine and the way people interact with it changing, but the processes for managing it are also undergoing big changes. In particular, the emergence of generative artificial intelligence creates new conditions for fundamental changes in process management at all levels – from individual medical organizations up to the federal level. How are approaches to healthcare management changing at the federal and regional levels and in medical organizations? What management changes in functional healthcare units and medical organizations have been most successful? How will digital technologies bring us closer to achieving our national healthcare goals in the near future? What potential opportunities and significant contradictions await us in the digital transformation of Russia’s state healthcare system?

Session topics :
Digitalization and AI Technologies

Moderator:

Vladimir Zelensky — First Deputy Minister of Health of the Russian Federation

Panellists:

Mikhail Bakhtin — Assistant Director for Medical Information Technology, Nikiforov’s All-Russian Center for Emergency and Radiation Medicine of the Emergencies Ministry of Russia

Olga Kobyakova — Director, Federal Research Institute for Health Organization and Informatics of the Ministry of Health of the Russian Federation

Alexander Kravchenko — Minister of Health of the Kaliningrad Region

Alexey Khripun — Moscow Government Minister; Head, Moscow Healthcare Department

World Trade Center Moscow, entrance No. 4, 2nd floor, conference hall 6

16:00–17:30

Gene Therapy: Past, Present, Future

Gene therapy is one of the most promising areas of the molecular medicine of the future. Gene therapy, which was originally developed primarily for the treatment of hereditary diseases, is now actively used to treat non-hereditary diseases. Currently, the most promising way to transfer genes during gene therapy is their inclusion in vectors that are built on the basis of retro- or adenoviruses. What are the benefits of personalized gene therapy? Which gene therapy approaches for treating hereditary diseases are the most effective today? Which segment of gene therapy drugs is developing the most actively and is most promising?

Session topics :
Genetic Technologies: Part of the Medicine of the Future

Moderator:

Pavel Makarevich — Head of the Laboratory of Gene Cell Therapy, Institute of Regenerative Medicine, Lomonosov Moscow State University

Panellists:

Vladimir Bozhenko — Head of the Department of Molecular Biology and Experimental Tumor Therapy, Russian Scientific Center of Radiology

Nikolay Ishmetov — Director of Special Projects, Russian Direct Investment Fund

Marina Popova — Founder, Advanced Gene and Cell Technologies (AGCT)

Denis Rebrikov — Vice-Rector for Scientific Work, Pirogov Russian National Research Medical University

14.02.2024

World Trade Center Moscow, entrance No. 4, 1st floor, conference hall No. 2. Gazprombank

10:00–11:30

The Emergence of Neurotechnologies of the Future

Technological progress has led to the creation of an entire myriad of technologies that aim to treat and rehabilitate neurological patients. Today, many neuro-technologies have found applications in medicine and have begun to be successfully introduced in domestic healthcare. Thus, over the last decade mechano-therapeutic rehabilitation devices (including robotic devices) have convincingly proven their effectiveness in restoring a patient’s movement and ability to walk. Virtual reality technologies that provide partial and complete immersion in a computer-generated space have become especially popular. Neural interface technologies (brain-computer interfaces) have gained serious and large-scale development over the past decade. Which neuro-technologies are the most promising in the present and in the near future? What lies ahead for us when various neuro-technologies reach critical mass and inevitably begin to hybridize with one another? What will the neural interface of the future look like? Will we move from the correction of neuro-pathologies to the augmentation of human capabilities? Will neural interfaces connect individuals into an ‘Internet of Brains’? Will it be possible to decode and reconstruct speech, thoughts, and feelings from brain activity? Will we understand the causes of neurodegenerative diseases and learn how to treat them?

Session topics :
Neurotechnologies in Healthcare

Moderator:

Veronika Skvortsova — Head, Federal Medical-Biological Agency of the Russian Federation

Panellists:

Andrey Davidyuk — Chairman of the Board of Directors, Motorica

Alexander Kolsanov — Rector, Samara State Medical University

Marya Lagarkova — General Director, Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency

Mikhail Martynov — Chief Freelance Neurologist, Ministry of Health of the Russian Federation; Professor of the Department of Neurology, Neurosurgery and Medical Genetics, N.I. Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation

Pavel Musienko — Head of the Laboratory of Neuroprosthetics, St. Petersburg State University; Head of Neurobiology, Sirius University of Science and Technology

Alexey Osadchy — Leading Research Fellow, AIRI Institute of Artificial Intelligence; Director, Centre for Bioelectric Interfaces, Institute for Cognitive Neuroscience, National Research University Higher School of Economics

Philipp Khaitovich — Professor, Vladimir Zelman Center for Neurobiology and Neurorehabilitation, Skoltech

World Trade Center Moscow, entrance No. 4, 2nd floor, conference hall 4

10:00–11:30

Artificial Intelligence and Computer Vision in Healthcare

With the accumulation of large amounts of medical data and the rapid development of analytical methods based on machine learning, logical and statistical models, AI tools can change the situation in the healthcare sector at its core. AI has the ability to personalize and take into account the characteristics of various parameters for different patient models, which allows for more accurate selection methods to diagnose and treat diseases, offer self-help tactics, and provide individual assistance. In the past few years, the use of AI in healthcare has been actively developing in Russia. In a number of regions, the models that are gradually taking hold and being used belong to one of two main groups: computer vision and medical decision support systems. Computer vision is used to assist radiologists. Instead of viewing each image, the doctor just needs to describe the changes that were uncovered by artificial intelligence. Medical decision support systems analyse a patient’s records from his/her medical history (data mining his/her electronic medical record), including the results of his tests, and inform this doctor of the most likely diagnosis. For the third year now, Moscow clinics have been using AI models to help doctors make diagnoses, which today have an accuracy rate for determining illness of 89%. A doctor’s work can be accelerated further by using AI models that automate the completion of medical documentation utilizing voice inputs. Concurrently, patient-oriented services for pre-clinical self-examination, assessment of a patient’s condition, as well as post-clinical rehabilitation (depending on the nosology) are also being actively developed. How will the introduction of AI technologies change the role of doctors in the healthcare system? What challenges might the system face when introducing AI? What will be the new organizational models of clinics? What will the clinic of the future look like? What areas of development of AI technologies in the world are the most promising? What benefits and advantages will the state, industry, and local populations receive from the introduction of AI technologies in healthcare? What has been the experience of Moscow clinics that have incorporated computer vision models? What opportunities will open up in the future due to the development of AI models?

Session topics :
Digitalization and AI Technologies

In partnership with Sberbank

Moderator:

Sergey Zhdanov — Managing Director, Director of the Health Industry Center, Sberbank

Panellists:

Dmitry Dylov — Director of the Department of Applied Medical Research, AIRI – Artificial Intelligence Research Institute; Associate Professor, Center for Artificial Intelligence Technologies, Skolkovo Institute of Science and Technology (Skoltech)

Vasily Ignatiev — General Director, R-Pharm

Kirill Kaem — Senior Vice-President for Innovations, Skolkovo Foundation

Pavel Pugachev — Deputy Minister of Health of the Russian Federation

Ilya Tyrov — Deputy Head, Moscow City Health Department

Alexey Fedorov — "Quantum Information Technologies" Scientific Group Head, Russian Quantum Center; Director, Institute of Physics and Quantum Engineering, MISIS University of Science and Technology

Evgeny Shlyakhto — General Director, Almazov National Medical Research Centre of the Ministry of Health of the Russian Federation; Chief Supernumerary Specialist Cardiologist of the Ministry of Health of the Russian Federation

World Trade Center Moscow, entrance No. 4, 2nd floor, conference hall 5

10:00–11:30

Artificial Intelligence: Saving Lives in Critical Conditions

AI has multiple and varied applications in the care of critically ill patients. It also has enormous potential for delivering emergency care and improving patient care outcomes. Methods and algorithms found in artificial intelligence and machine learning are already being used in real clinical practice. Today, these methods are being developed and applied in predominantly diagnostic areas, which use programmes that analyse data from patient records in order to recognize and identify patterns in them. In the nearest future, artificial intelligence has all the prerequisites to be actively utilized to predict a patient’s deteriorating condition and whether the disease is progressing. Likewise, AI can monitor changes in pathological processes, carry out continual pain assessment of patients in intensive care units, as well as provide prompt assistance to doctors in making complex clinical decisions. In addition, by 2030, we should expect AI to be an integral part of treatment algorithms, not only within medical decision support systems, but also in surgery, anaesthesiology, and resuscitation. What are the key principles for creating AI systems, and why are they needed? What are the potential applications of artificial intelligence in critical care? What are the most promising areas for the practical application of AI systems in the medicine of the future? What challenges does AI need to overcome today before it becomes a routine part of clinical practice? How can artificial intelligence revolutionize the care of critically ill patients and dramatically improve the efficiency of healthcare systems in the near future?

Session topics :
Digitalization and AI Technologies

Moderator:

Boris Axelrod — Chairman of the Board, Moscow Scientific Society of Anesthesiologists and Resuscitators; Head of the Department of Anesthesiology and Reanimation, Russian National Research Center of Surgery named after B.V. Petrovsky

Panellists:

Sergey Bagnenko — Chief Freelance Specialist in Emergency Medical Services of the Ministry of Health of the Russian Federation; Rector, Pavlov First St. Petersburg State Medical University of the Ministry of Health of the Russian Federation

Artem Kuzovlev — Deputy Director – Head, V.A. Negovsky Scientific Research Institute of General Reanimatology; Vice President, Federation of Anaesthesiologists and Reanimatologists (FAR)

Irina Pakhomova — Head of the Development of Information Systems in Anesthesiology and Resuscitation Group, Information Technology Center, Academician B.V. Petrovsky Russian Scientific Centre of Surgery

Sergey Petrikov — Director, N.V. Sklifosovsky Research Institute for Emergency Medicine

Denis Protsenko — Chief Freelance Specialist in Anesthesiology and Resuscitation of Moscow Healthcare Department; Director, Kommunarka Multidisciplinary Clinical Center

Valery Subbotin — Head of the Center for Anesthesiology and Resuscitation, Loginov Moscow Clinical Scientific Center; Leading Researcher, Laboratory of Clinical Pathophysiology of Critical States, V.A. Negovsky Scientific Research Institute of General Reanimatology

Boris Teplykh — Chief of the Department of Anesthesiology and Intensive Care, N.I. Pirogov National Medical and Surgical Center of the Ministry of Health of the Russian Federation

Sergey Tsarenko — Chief Freelance Specialist in Anesthesiology and Resuscitation of the Ministry of Health of the Russian Federation; Director, National Medical Research Center "Treatment and Rehabilitation Center" of the Ministry of Health of the Russian Federation

World Trade Center Moscow, entrance No. 4, 2nd floor, conference hall 6

10:00–11:30

Medical Equipment and Drugs for Nuclear Medicine

Nuclear medicine is developing rapidly in Russia with medical equipment becoming more technologically advanced and more new drugs and innovative techniques for treating oncological, cardiological, neurological and other harmful diseases coming onto the scene with each passing year. Even so, more favorable conditions for developing and applying these advanced forms of nuclear medicine could be created if cooperation between the medical, research and business communities in conjunction with international cooperation between BRICS member countries among others could be harnessed to establish important infrastructure, therapeutic and diagnostic equipment, isotope products, and radiopharmaceuticals. Support from industry regulators is still required and a balance must be struck between import substitution and the exclusive market rights of services and technologies to ensure continued development of nuclear medicine and state-of-the-art equipment and drugs in Russia. What are the current trends in the development and application of medical equipment and drugs for nuclear medicine? What support measures from the government and industry regulators are needed to establish an advanced development model for nuclear medicine? What affect does cooperation between the medical, scientific, and business communities have on the quality of new diagnostic and treatment methods and the speed with which they can be introduced?

Session topics :
Biotechnologies in Personalized Healthcare, Including Active Longevity and Preventive Medicine Technologies

In partnership with the State Atomic Energy Corporation ROSATOM

Moderator:

Kirill Komarov — First Deputy General Director, Director of the Development and International Business Unit, State Atomic Energy Corporation ROSATOM

Panellists:

Alexey Ansheles — Leading Researcher, Radiologist, Academician E.I. Chazov National Medical Research Center for Cardiology of the Ministry of Health of the Russian Federation

Badma Bashankaev — Deputy of the State Duma of the Federal Assembly of the Russian Federation; Member of the State Duma Committee on Health Protection

Tigran Gevorkyan — Deputy Director for the Implementation of Federal Projects, N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation

Sergey Glagolev — Deputy Minister of Health of the Russian Federation

Julia Dyakova — First Deputy Director for Science, National Research Center "Kurchatov Institute"

Andrey Stanzhevsky — Deputy Director for Research, Academician A.M. Granova Scientific Center of Radiology and Surgical Technologies of the Ministry of Health of the Russian Federation

Vladimir Chernov — Deputy Director for Science and Innovation, Tomsk National Research Medical Center of the Russian Academy of Sciences

Vasiliy Shpak — Deputy Minister of Industry and Trade of the Russian Federation

World Trade Center Moscow, entrance No. 4, 1st floor, conference hall No. 2. Gazprombank

12:00–13:30

Why Does the Brain Need to Connect to a Computer?

Brain-computer interfaces (BCIs) are devices that read signals directly from (or transmit them to) the brain, bypassing our senses. The number of areas in which BCIs can be applied is truly vast: in the early diagnosis and treatment of neurological conditions and brain diseases (including Parkinson's disease, epilepsy, depression, and hypertension); in mental health monitoring; in the restoration of lost cognitive abilities and motor functions; in the ability to transform thought and intention into speech; and in areas where objects can be controlled by the power of thought. In addition to medicine and healthcare, such technologies can also be used in smart homes. In one form or another, neural interfaces are one of the recent technological trends that cannot help but develop further. Today, humanity has already approached the dividing line between science fiction and real everyday life, and it will be very interesting to explore what advantages lie ahead for people when this line is crossed. What sets apart the current state of world technologies in the field of neural interfaces? Domestic versus foreign markets of neuro-technologies: what are their difference and what is the interest of large businesses? What are the most common applications of BCIs known today? What are the main advantages and disadvantages of BCIs today? What is preventing the widespread adoption of BCIs?

Session topics :
Digitalization and AI Technologies

In partnership with Gazprombank

Moderator:

Dmitry Zauers — Deputy Chairman of the Management Board, Gazprombank

Panellists:

Nikita Bukreev — General Director, SensoryLAB

Sergey Ivanov — Executive Director, Member of the Board of Directors, EFKO Management Company

Mikhail Lebedev — Chief Researcher, I.M. Sechenov Institute of Evolutionary Physiology and Biochemistry of the Russian Academy of Sciences

Maxim Ostras — Director of Strategic Development, LIFT Center; Head, QLU

Vasily Popkov — Head of the Scientific Group "Invasive Neural Interfaces", Institute of Artificial Intelligence, Lomonosov Moscow State University (MSU)

Alexey Khalezov — Lead Architect, Neiry

World Trade Center Moscow, entrance No. 4, 2nd floor, conference hall 4

12:00–13:30

Development of Nuclear Medicine in Russia: Present and Future

Nuclear technologies in medicine are advanced methods for diagnosing and treating oncological, neurological, and cardiovascular diseases. However, for the effective use of such technology in healthcare, it is essential to create a unified legislative and regulatory framework, improve the system of state control and supervision, as well as coordinate how scientific research and technological developments are introduced into clinical practice. Only an interdisciplinary and systematic approach will ensure that key objectives for the creation of nuclear medicine centres in Russia are carried out, as well as ensure efficiency, quality, and safety when using nuclear physics technologies to provide high-tech medical care. The effective implementation of these objectives requires the development of a network of nuclear medicine infrastructure, as well as extremely vital practical international cooperation. Which trends and main focus areas of nuclear medicine are relevant today? What is the reason for the growing need in Russia and neighbouring countries for nuclear technologies in medicine? What measures are required from industry regulators to achieve an advanced model for the development of nuclear medicine?

Session topics :
Biotechnologies in Personalized Healthcare, Including Active Longevity and Preventive Medicine Technologies

Moderator:

Mikhail Kovalchuk — President, National Research Centre "Kurchatov Institute"

Panellists:

Vladislav Baranov — Chairman of the Board of Directors, "My Medical Center" Group of Companies

Sergey Deev — Professor, Chief Researcher, Academicians M.M. Shemyakin and Y.A. Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences

Stepan Kalmykov — Vice-President, Russian Academy of Sciences

Kirill Komarov — First Deputy General Director, Director of the Development and International Business Unit, State Atomic Energy Corporation ROSATOM

Konstantin Kotenko — Director, Academician B.V. Petrovsky Russian Scientific Center of Surgery

Olga Krivonos — Deputy Chief of Staff of the Government of the Russian Federation

Front row participants:

Sergey Ivanov — Director, A.F. Tsyb Medical Radiological Research Center – branch of the National Medical Research Center for Radiology of the Ministry of Health of the Russian Federation; Chief Freelance Oncologist of the Central Federal District of the Ministry of Health of the Russian Federation

Pavel Rumyantsev — Deputy Chief Physician, Chief Specialist Radiation Oncologist, Doctor of Medical Sciences, My Medical Center

Vladimir Shevchenko — Rector, National Research Nuclear University MEPhI

World Trade Center Moscow, entrance No. 4, 2nd floor, conference hall 5

12:00–13:30

Value-Based Healthcare: A New Approach to Patient Engagement

One of the key targets for modernizing Russia’s healthcare system is to become value-based orientated and, in doing so, create a functional ecosystem to support this while uniting regional, federal, and independent clinical information systems, for which patients will be assigned a central role. By ecosystem we mean the elimination of information asymmetry between the doctor and the patient, the creation of a ‘Digital Medical Profile’ for each citizen, the introduction of telemedicine and remote health monitoring using the ‘Personal Medical Assistant Platform’, the use of medical products with the function of remote data transfer and the proactive service ‘Digital Process Diaries’, and accumulating clinical recommendations and standards of medical care to identify health risks. The realization of value-based medicine will require forward-thinking implementation as its scope will increasingly extend beyond mere individual healthcare organizations, and will involve multi-stakeholder collaboration at local, national, and international levels, and will undoubtedly face resistance from healthcare professionals whose roles will be partially replaced by new technologies. What steps are needed from the medical community, business, and government to implement a new approach for interaction with patients? What challenges accompany the transition to a patient-centred healthcare system? What are the development prospects for value-based healthcare in Russia and around the world?

Session topics :
Digitalization and AI Technologies

Moderator:

Olga Kobyakova — Director, Federal Research Institute for Health Organization and Informatics of the Ministry of Health of the Russian Federation

Panellists:

Saida Gadzhieva — Deputy Head of the Moscow City Health Department

Damir Engalychev — Medical Director, Element Laboratory

Sergey Zhdanov — Managing Director, Director of the Health Industry Center, Sberbank

Vladimir Zelensky — First Deputy Minister of Health of the Russian Federation

Sergey Lezhnin — Chief Executive Officer, RT DOKTIS

Vitaliy Omelyanovskiy — General Director, Center for Healthcare Quality Assessment and Control of the Ministry of Health of the Russian Federation

Anna Sharipova — Managing Director for National Projects, Russian Technologies State Corporation

World Trade Center Moscow, entrance No. 4, 2nd floor, conference hall 6

12:00–13:30

The Place of Popular Science in Science: How to Attract and Promote

Information spreads – in great quantity – in the modern world as quickly as technology develops. Unfortunately, reliable, easily navigable sources of information tend to be limited to more traditional sources, and the industry lacks authoritative information hubs. Should platforms be created for related content where scientists can systematically access verified information? How should we be safeguarding new formats that can be accessed by young people? How can we share complex ideas without harming the quality of the material?

Session topics :
An Ecosystem for Future Technologies

Moderator:

Marina Mishunkina — First Deputy General Director, Argumenty i Facty

Panellists:

Dmitry Komendantov — Government Relations Director, VK

Alexander Korsunsky — Professor, Skoltech Center for Systems Engineering

Artem Krasheninnikov — Director General, Communication Agency "Pictures"

Denis Sekirinsky — Deputy Minister of Science and Higher Education of the Russian Federation

Stanislav Straupe — Head of Quantum Computing Sector, Center for Quantum Technologies, Lomonosov Moscow State University; Head of the Scientific Group of Atomic and Optical Quantum Computing, Russian Quantum Center

Andrey Timonov — Acting Director of the Communications Department, State Atomic Energy Corporation ROSATOM

Leonid Shlyakhover — President, Foundation for the Development of Scientific and Cultural Relations Challenge

Front row participant:

Valeria Kasamara — Director, Association of Organizers of Student Olympiads "I am a Professional"

World Trade Center Moscow, entrance No. 4, 2nd floor, conference hall 3

16:30–18:30

Modern Medical Technologies. The Challenges of Tomorrow: Getting the Jump on Time . Plenary session

Address by the President of the Russian Federation Vladimir Putin

Moderator:

Grigory Trubnikov — Director, Joint Institute for Nuclear Research

Panellists:

Vasily Akimkin — Director, Central Research Institute of Epidemiology

Vsevolod Belousov — Director, Federal Center of Brain Research and Neurotechnologies of the Federal Medical Biological Agency

Raul Gainetdinov — Director, Institute of Translational Biomedicine, Saint Petersburg State University

Ilya Eremin — Deputy Director for Research, Academician B.V. Petrovsky Russian Scientific Center for Surgery

Alexander Makarov — Director, V.A. Engelhardt Institute of Molecular Biology of the Russian Academy of Sciences

Igor Khatkov — Director, GBUZ Moscow Clinical Scientific Center named after Loginov of the Department of Healthcare of Moscow